SlideShare una empresa de Scribd logo
1 de 38
Hyperprolactinemia
Dr Manal Behery
Hypothalamo-Pituitary-Ov-Ut Axis
CNS
Hypothalamus
Pituitary
Ovary
Uterus
Outflow tract
Prolactin
Cell of Origin
PRL is 199 polypeptide
hormone
made by the pituitary
lactotrophs.
Synthesis and metabolism
• Normal serum level= 10-
25 ng/ml,
• half life =20 minutes
• Metabolized in liver and
kidney
Types(isoforms)
• Little PRL:
• 80-90%, MW 23000K,
• non glycosylated
• high receptor binding
bioactivity
• full immuno-activity
Isoforms
• Big PRL:
• 8-20%, MW 50000K,
mixture of dimeric
and trimeric forms of
G-PRL
• Big-big PRL:
• 1-5%, MW 100000K,
• polymeric
Control of prolactin release:
• 1- Prolactin inhibiting factor (dopamine) → ↓
prolactin release.
• 2- Estrogen → ↑ prolactin release.
• 3- TRH “thyrotropin releasing hormone” → ↑
prolactin release.
– Sleep
– Satiety
– Stress&Exercise
– Sex
– Second half Menstrual cycle(luteal phase)
– Suckling
If a woman's prolactin level is elevated the first time it is tested,
a second sample should be checked when she is fasting and
non-stressed.
Physiologic conditions
Pharmacological conditions :
• -Estrogen containing drugs/ pills.
• -Antidopaminergic drugs:
• - Tricyclic antidepressant (TCA)
• -Anti emetics → meteclopromide.
• Antihypertensives: α methyl dopa &reserpine
• Histamine H2-receptor antagonists
• Stimulation of serotoninergic system
Amphetamines Hallucinogens
Pathological condition
Pathological condition
• 1. Pituitary:
• * Pituitary adenoma
"Prolactinoma".
• * Growth H. secreting
tumor.
2. Hypothalamic:
• * inhibits PIF (dopamine) secretion or access
to pituitary.
• * Functional "idiopathic“
*Organic lesion: trauma, infection, tumors.
• * Psychological disturbance.
•A craniopharyngioma is a benign tumor that
develops near the pituitary gland .
• most commonly in childhood and adolescence
and
•in later adult life.
compresses the pituitary stalk or gland, the tumor
can cause partial or complete pituitary hormone de
ficiency.
Diagrammatic representation of empty sella syndrome.
A, Normal anatomic relationship.
B, C, and D, Progression in development of empty sella syndrome.
Note thinning of floor and symmetric enlargement of sella turcica.
Empty sella sydrome
3. Primary hypothyroidism
• ↑ TRH → stimulates lactotrophs to ↑
prolactin secretion.
Other causes
 Liver cell failure- Chronic renal failure.
Chest wall disease: burn- scar- Herpes
Zoster.
Ectopic secretion:Hypernephroma of
kidney. * Oat cell carcinoma of lung
 hyperestrogenic states e.g PCO
Pathologic conditions
• Hypothalamic lesions
Craniopharyngioma
Glioma
Granuloma
Stalk transection
Irradiation damage
Pseudocysts
• Pituitary tumors
Cushing disease
Acromegaly
Prolactinoma
• Reflex causes
Chest wall injury
herpes zoster neuritis
Upper abdominal op
• Hypothyroidism
• Renal failure
• Ectopic pdoduction
Bronchogenic carcinoma
Hypernephroma
(endocannabinoids)
How prolactin act?
A- Inhibition of pulsatile GnRH secretion
1- Hyperprolactinemia inhibit GnRH activity by
interacting with hypothalamic DA and opioid
system via the short-loop feedback mechanism.
CNS-hypothalamus-pituitary
ovary-uterus interaction
Neural control Chemical control
Dopamine
(-)
Norepinephrine
(+)
Endorphins
(-)
Hypothalamus
GnRH
Ant. pituitary
FS, LHH
Ovaries
Uterus
ProgesteroneEstrogen
Menses
–± ?
B. Interference with gonadotrophin action in ovary
2-Decreased ovarian sensitivity to pituitary
gonadotropin
C-Inhibition of FSH-directed ovarian
aromatase
• 3-impaired follicular development
D- Inhibition of progesterone synthesis
4-Impaired ovarian strediogensis
Clinical Manifestation
• 1- Galactorrhea: Only in 30- 60 % of cases of
hyperprolactinemia due to :
• 2- Infertility: due to:- Anovulation luteal
phase defect
• 3- Oligohypomenorrhea , even amenorrhea
• 4- Hirsutism due to decreased SHBG.
• 5 -Decreased libido &osteoporosis
Diagnosis
1- History:
• of a cause( Drug intake,thyroid,renal...)
• of a symptom (galactorrhea,menstrual
problem, ...).
2- Examination
• - Visual field defect → pituitary adenoma.
• - Thyroid → goiter.
• - Breast → examined for galactorrhea.
• - Chest wall → burn, scar.
1- Prolactin level:
• > 100 ng / ml → suggestive of adenoma.
• > 300 ng/ ml → diagnostic of adenoma.
• > 2000 ng/ ml→cavernous sinus invasion.
2- MRI brain:
• - Detect all macroadenoma (> 1cm).
• - Detect 70% of
microadenoma(<1cm).
• 3- Thyroid function tests.
• 4- Others : - Liver function test. -
Kidney function test.
Treatment of the cause
• - Treatment of hypothyroidism (thyroxine).
• -stop drugs causing hyperprolactinemia.
• -PCO,Liver,renal,.....
2- Dopamine agonists:
• Acts on D2 receptors but also D1,Alpha adrenergic.
• 1. Bromocreptine (parlodel): tablet = 2.5 mg oral
or even vaginal.- start with ½ tablet → ↑
gradually ,better during meals.
• - Side effects1- Nausea & vomiting.
• 2- Postural hypotension.3- Headache.
• 4- Abdominal cramps.
. Lisuride (dopergine):
• More potent. - Less side effects.
3. Cabergoline (dostinex):
• Selective D2 Agonist tablet 0.5 mg
• - Long acting.
• - More potent.
• - Less side effects
. Quinagolid (norprolac):
• non-ergot preparation (D2 receptors),
• less side effects
3- Trans-sphenoid surgery:
• For Pituitary adenoma only if :
• - No response to medical ttt.
• - Causing visual field defect.
• - TTT is not tolerable.
Hyperprolactinema for undergraduate

Más contenido relacionado

La actualidad más candente

Gyn Hyperprolactinemia
Gyn HyperprolactinemiaGyn Hyperprolactinemia
Gyn Hyperprolactinemia
guest9dc181
 
gynaecology.Primary amenorrhea.(dr.sundus)
gynaecology.Primary amenorrhea.(dr.sundus)gynaecology.Primary amenorrhea.(dr.sundus)
gynaecology.Primary amenorrhea.(dr.sundus)
student
 
Abnormal uterine bleeding
Abnormal uterine bleedingAbnormal uterine bleeding
Abnormal uterine bleeding
drmcbansal
 

La actualidad más candente (20)

Key points in prescription writing in menopause, Dr. Sharda Jain, Dr. Jyoti A...
Key points in prescription writing in menopause, Dr. Sharda Jain, Dr. Jyoti A...Key points in prescription writing in menopause, Dr. Sharda Jain, Dr. Jyoti A...
Key points in prescription writing in menopause, Dr. Sharda Jain, Dr. Jyoti A...
 
Kallmann syndrome
Kallmann syndromeKallmann syndrome
Kallmann syndrome
 
Hyperprolactinemia case Presentation
Hyperprolactinemia case PresentationHyperprolactinemia case Presentation
Hyperprolactinemia case Presentation
 
GnRH Agonists & Antagonists
GnRH Agonists & AntagonistsGnRH Agonists & Antagonists
GnRH Agonists & Antagonists
 
Gyn Hyperprolactinemia
Gyn HyperprolactinemiaGyn Hyperprolactinemia
Gyn Hyperprolactinemia
 
Amenorrhea
AmenorrheaAmenorrhea
Amenorrhea
 
Kallmann syndrome
Kallmann syndromeKallmann syndrome
Kallmann syndrome
 
Gestational trophoblastic disease part 2-1 - copy
Gestational trophoblastic disease part   2-1 - copyGestational trophoblastic disease part   2-1 - copy
Gestational trophoblastic disease part 2-1 - copy
 
Thyroid disorders in pregnancy
Thyroid disorders in pregnancyThyroid disorders in pregnancy
Thyroid disorders in pregnancy
 
Hyperprolactinemia work up
Hyperprolactinemia work upHyperprolactinemia work up
Hyperprolactinemia work up
 
Use of progesterone in obstetrics &amp; gynaecology namkha presents
Use of progesterone in obstetrics &amp; gynaecology namkha presentsUse of progesterone in obstetrics &amp; gynaecology namkha presents
Use of progesterone in obstetrics &amp; gynaecology namkha presents
 
gynaecology.Primary amenorrhea.(dr.sundus)
gynaecology.Primary amenorrhea.(dr.sundus)gynaecology.Primary amenorrhea.(dr.sundus)
gynaecology.Primary amenorrhea.(dr.sundus)
 
Hyperprolactinema for undergraduate updated
Hyperprolactinema for undergraduate  updatedHyperprolactinema for undergraduate  updated
Hyperprolactinema for undergraduate updated
 
Molar pregnancy
Molar pregnancyMolar pregnancy
Molar pregnancy
 
Thyroid in pregnancy
Thyroid in pregnancyThyroid in pregnancy
Thyroid in pregnancy
 
Endometrial cancer JNMCH AMU ALIGARH
Endometrial cancer JNMCH AMU ALIGARHEndometrial cancer JNMCH AMU ALIGARH
Endometrial cancer JNMCH AMU ALIGARH
 
Puberty menorrhagia Dr Sharda Jain , Dr Jyoti Agarwal
Puberty menorrhagia  Dr Sharda Jain , Dr Jyoti Agarwal Puberty menorrhagia  Dr Sharda Jain , Dr Jyoti Agarwal
Puberty menorrhagia Dr Sharda Jain , Dr Jyoti Agarwal
 
Abnormal uterine bleeding
Abnormal uterine bleedingAbnormal uterine bleeding
Abnormal uterine bleeding
 
Gn rh analogues in gynaecology
Gn rh analogues in gynaecologyGn rh analogues in gynaecology
Gn rh analogues in gynaecology
 
Mullerian anomalies
Mullerian anomaliesMullerian anomalies
Mullerian anomalies
 

Destacado

Hyperprolactinemia 3
Hyperprolactinemia  3Hyperprolactinemia  3
Hyperprolactinemia 3
guest9dc181
 

Destacado (20)

Hyperprolactinemia 3
Hyperprolactinemia  3Hyperprolactinemia  3
Hyperprolactinemia 3
 
Hydrops fetails for undergranuate
Hydrops fetails for  undergranuateHydrops fetails for  undergranuate
Hydrops fetails for undergranuate
 
Cin&cancer cervix undergraduate
Cin&cancer cervix undergraduateCin&cancer cervix undergraduate
Cin&cancer cervix undergraduate
 
Induction of labor& pain reief inlabor for undergraduate
Induction of labor& pain reief inlabor for undergraduateInduction of labor& pain reief inlabor for undergraduate
Induction of labor& pain reief inlabor for undergraduate
 
Managment of labor for undergraduate
Managment of labor for undergraduateManagment of labor for undergraduate
Managment of labor for undergraduate
 
Ventose and forceps delivery for undergraduate
Ventose and forceps delivery for undergraduateVentose and forceps delivery for undergraduate
Ventose and forceps delivery for undergraduate
 
Fetal monitoring for undergraduate
Fetal monitoring  for undergraduateFetal monitoring  for undergraduate
Fetal monitoring for undergraduate
 
OSCE student exam in Obstetrics &Gynecology Zagazig University 2014
OSCE student exam in Obstetrics &Gynecology Zagazig University 2014OSCE student exam in Obstetrics &Gynecology Zagazig University 2014
OSCE student exam in Obstetrics &Gynecology Zagazig University 2014
 
Osce revision in obstetrics and gynecology
Osce revision in obstetrics and gynecologyOsce revision in obstetrics and gynecology
Osce revision in obstetrics and gynecology
 
Osce obstetrics for undergraduate
Osce obstetrics for undergraduateOsce obstetrics for undergraduate
Osce obstetrics for undergraduate
 
Hyperprolactinemia endocrin society
Hyperprolactinemia endocrin societyHyperprolactinemia endocrin society
Hyperprolactinemia endocrin society
 
Hirsutism for undergraduate
Hirsutism for undergraduateHirsutism for undergraduate
Hirsutism for undergraduate
 
Prolactin
ProlactinProlactin
Prolactin
 
Postmenopausal bleeding for undergraduate
Postmenopausal bleeding for undergraduatePostmenopausal bleeding for undergraduate
Postmenopausal bleeding for undergraduate
 
Obstructed labor and shoulder dystocia for undergraduate
Obstructed labor and shoulder dystocia for undergraduateObstructed labor and shoulder dystocia for undergraduate
Obstructed labor and shoulder dystocia for undergraduate
 
Amenorrhea for undergraduate
Amenorrhea for undergraduateAmenorrhea for undergraduate
Amenorrhea for undergraduate
 
Fibroid for undergraduate
Fibroid for undergraduateFibroid for undergraduate
Fibroid for undergraduate
 
Maternal obstetric injuries for undergraduate
Maternal obstetric injuries for undergraduateMaternal obstetric injuries for undergraduate
Maternal obstetric injuries for undergraduate
 
Episotomy for undergraduate
Episotomy for undergraduateEpisotomy for undergraduate
Episotomy for undergraduate
 
Contraception for undergraduate
Contraception for undergraduateContraception for undergraduate
Contraception for undergraduate
 

Similar a Hyperprolactinema for undergraduate

5919003-230817133315-c77bnnnhhhca1c8.pdf
5919003-230817133315-c77bnnnhhhca1c8.pdf5919003-230817133315-c77bnnnhhhca1c8.pdf
5919003-230817133315-c77bnnnhhhca1c8.pdf
MitikuTeka1
 
Pituitary Adenomas-Clinical Neuro-Ophthalmic and Radiological Evaluation.pdf
Pituitary Adenomas-Clinical Neuro-Ophthalmic and Radiological Evaluation.pdfPituitary Adenomas-Clinical Neuro-Ophthalmic and Radiological Evaluation.pdf
Pituitary Adenomas-Clinical Neuro-Ophthalmic and Radiological Evaluation.pdf
FrankyQ2
 

Similar a Hyperprolactinema for undergraduate (20)

Lecture 1. hyperpituitarism
Lecture 1. hyperpituitarismLecture 1. hyperpituitarism
Lecture 1. hyperpituitarism
 
Pitutary tumors and management
Pitutary tumors and managementPitutary tumors and management
Pitutary tumors and management
 
Pituitary hormones &amp;_their_hypothalamic
Pituitary hormones &amp;_their_hypothalamicPituitary hormones &amp;_their_hypothalamic
Pituitary hormones &amp;_their_hypothalamic
 
Pitutary gland : A Medical Approach
Pitutary gland : A Medical ApproachPitutary gland : A Medical Approach
Pitutary gland : A Medical Approach
 
Prolactinoma
ProlactinomaProlactinoma
Prolactinoma
 
cushings.pptx
cushings.pptxcushings.pptx
cushings.pptx
 
5919003-230817133315-c77bnnnhhhca1c8.pdf
5919003-230817133315-c77bnnnhhhca1c8.pdf5919003-230817133315-c77bnnnhhhca1c8.pdf
5919003-230817133315-c77bnnnhhhca1c8.pdf
 
Pathology of Endocrine system.ppt
Pathology of Endocrine system.pptPathology of Endocrine system.ppt
Pathology of Endocrine system.ppt
 
Pitutary part 1
Pitutary part 1Pitutary part 1
Pitutary part 1
 
Pituitary Adenomas-Clinical Neuro-Ophthalmic and Radiological Evaluation.pdf
Pituitary Adenomas-Clinical Neuro-Ophthalmic and Radiological Evaluation.pdfPituitary Adenomas-Clinical Neuro-Ophthalmic and Radiological Evaluation.pdf
Pituitary Adenomas-Clinical Neuro-Ophthalmic and Radiological Evaluation.pdf
 
Prolactinoma & men syndromes
Prolactinoma & men syndromesProlactinoma & men syndromes
Prolactinoma & men syndromes
 
Hyper prolactemia pdf for studying and others
Hyper prolactemia pdf for studying and othersHyper prolactemia pdf for studying and others
Hyper prolactemia pdf for studying and others
 
Prolactinoma endocrinology neurosurgery.pptx
Prolactinoma endocrinology neurosurgery.pptxProlactinoma endocrinology neurosurgery.pptx
Prolactinoma endocrinology neurosurgery.pptx
 
Approach to pitiutary diseases
Approach to pitiutary diseasesApproach to pitiutary diseases
Approach to pitiutary diseases
 
Pituitary april-12 د فائزة
Pituitary april-12 د فائزة Pituitary april-12 د فائزة
Pituitary april-12 د فائزة
 
PROLACTIN & REPRODUCTION
PROLACTIN & REPRODUCTIONPROLACTIN & REPRODUCTION
PROLACTIN & REPRODUCTION
 
Proteinuria
ProteinuriaProteinuria
Proteinuria
 
HYPOPITUITARISM.pptx
HYPOPITUITARISM.pptxHYPOPITUITARISM.pptx
HYPOPITUITARISM.pptx
 
Adrenal gland disorders
Adrenal gland disordersAdrenal gland disorders
Adrenal gland disorders
 
Prolactin
ProlactinProlactin
Prolactin
 

Más de Faculty of Medicine,Zagazig University,EGYPT

Más de Faculty of Medicine,Zagazig University,EGYPT (12)

PID for undergraduate
PID for  undergraduatePID for  undergraduate
PID for undergraduate
 
Normal labor for undergraduate
Normal labor for undergraduateNormal labor for undergraduate
Normal labor for undergraduate
 
Partograph and labor dystocia for undergraduate
Partograph and labor dystocia for undergraduatePartograph and labor dystocia for undergraduate
Partograph and labor dystocia for undergraduate
 
Twins for undergraduate
Twins for undergraduateTwins for undergraduate
Twins for undergraduate
 
Female bony pelvis and fetal skull for undergraduate
Female   bony pelvis and fetal skull for undergraduateFemale   bony pelvis and fetal skull for undergraduate
Female bony pelvis and fetal skull for undergraduate
 
Gestational trophoblastic disease for undergraduate
Gestational trophoblastic disease for undergraduateGestational trophoblastic disease for undergraduate
Gestational trophoblastic disease for undergraduate
 
Ectopic pregnancy for undergraduate
Ectopic pregnancy for undergraduateEctopic pregnancy for undergraduate
Ectopic pregnancy for undergraduate
 
Maternal changes during pregnancy for undergraduate
Maternal changes during pregnancy for undergraduateMaternal changes during pregnancy for undergraduate
Maternal changes during pregnancy for undergraduate
 
Osce in obstetrics&gynecology for undergraduate
Osce in obstetrics&gynecology for undergraduateOsce in obstetrics&gynecology for undergraduate
Osce in obstetrics&gynecology for undergraduate
 
Mm accreta
Mm accretaMm accreta
Mm accreta
 
Placenta accreta for post graduate
Placenta accreta for post graduatePlacenta accreta for post graduate
Placenta accreta for post graduate
 
New trends in the treatment of placenta accreta
New trends in the treatment of placenta accretaNew trends in the treatment of placenta accreta
New trends in the treatment of placenta accreta
 

Último

Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
kauryashika82
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 

Último (20)

Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 

Hyperprolactinema for undergraduate

  • 3. Prolactin Cell of Origin PRL is 199 polypeptide hormone made by the pituitary lactotrophs.
  • 4. Synthesis and metabolism • Normal serum level= 10- 25 ng/ml, • half life =20 minutes • Metabolized in liver and kidney
  • 5. Types(isoforms) • Little PRL: • 80-90%, MW 23000K, • non glycosylated • high receptor binding bioactivity • full immuno-activity
  • 6. Isoforms • Big PRL: • 8-20%, MW 50000K, mixture of dimeric and trimeric forms of G-PRL • Big-big PRL: • 1-5%, MW 100000K, • polymeric
  • 7. Control of prolactin release: • 1- Prolactin inhibiting factor (dopamine) → ↓ prolactin release. • 2- Estrogen → ↑ prolactin release. • 3- TRH “thyrotropin releasing hormone” → ↑ prolactin release.
  • 8. – Sleep – Satiety – Stress&Exercise – Sex – Second half Menstrual cycle(luteal phase) – Suckling If a woman's prolactin level is elevated the first time it is tested, a second sample should be checked when she is fasting and non-stressed. Physiologic conditions
  • 9. Pharmacological conditions : • -Estrogen containing drugs/ pills. • -Antidopaminergic drugs: • - Tricyclic antidepressant (TCA) • -Anti emetics → meteclopromide. • Antihypertensives: α methyl dopa &reserpine • Histamine H2-receptor antagonists • Stimulation of serotoninergic system Amphetamines Hallucinogens
  • 11. Pathological condition • 1. Pituitary: • * Pituitary adenoma "Prolactinoma". • * Growth H. secreting tumor.
  • 12. 2. Hypothalamic: • * inhibits PIF (dopamine) secretion or access to pituitary. • * Functional "idiopathic“ *Organic lesion: trauma, infection, tumors. • * Psychological disturbance.
  • 13. •A craniopharyngioma is a benign tumor that develops near the pituitary gland . • most commonly in childhood and adolescence and •in later adult life. compresses the pituitary stalk or gland, the tumor can cause partial or complete pituitary hormone de ficiency.
  • 14. Diagrammatic representation of empty sella syndrome. A, Normal anatomic relationship. B, C, and D, Progression in development of empty sella syndrome. Note thinning of floor and symmetric enlargement of sella turcica. Empty sella sydrome
  • 15. 3. Primary hypothyroidism • ↑ TRH → stimulates lactotrophs to ↑ prolactin secretion.
  • 16. Other causes  Liver cell failure- Chronic renal failure. Chest wall disease: burn- scar- Herpes Zoster. Ectopic secretion:Hypernephroma of kidney. * Oat cell carcinoma of lung  hyperestrogenic states e.g PCO
  • 17. Pathologic conditions • Hypothalamic lesions Craniopharyngioma Glioma Granuloma Stalk transection Irradiation damage Pseudocysts • Pituitary tumors Cushing disease Acromegaly Prolactinoma • Reflex causes Chest wall injury herpes zoster neuritis Upper abdominal op • Hypothyroidism • Renal failure • Ectopic pdoduction Bronchogenic carcinoma Hypernephroma
  • 20. A- Inhibition of pulsatile GnRH secretion 1- Hyperprolactinemia inhibit GnRH activity by interacting with hypothalamic DA and opioid system via the short-loop feedback mechanism.
  • 21. CNS-hypothalamus-pituitary ovary-uterus interaction Neural control Chemical control Dopamine (-) Norepinephrine (+) Endorphins (-) Hypothalamus GnRH Ant. pituitary FS, LHH Ovaries Uterus ProgesteroneEstrogen Menses –± ?
  • 22. B. Interference with gonadotrophin action in ovary 2-Decreased ovarian sensitivity to pituitary gonadotropin
  • 23. C-Inhibition of FSH-directed ovarian aromatase • 3-impaired follicular development
  • 24. D- Inhibition of progesterone synthesis 4-Impaired ovarian strediogensis
  • 25. Clinical Manifestation • 1- Galactorrhea: Only in 30- 60 % of cases of hyperprolactinemia due to : • 2- Infertility: due to:- Anovulation luteal phase defect • 3- Oligohypomenorrhea , even amenorrhea • 4- Hirsutism due to decreased SHBG. • 5 -Decreased libido &osteoporosis
  • 27. 1- History: • of a cause( Drug intake,thyroid,renal...) • of a symptom (galactorrhea,menstrual problem, ...).
  • 28. 2- Examination • - Visual field defect → pituitary adenoma. • - Thyroid → goiter. • - Breast → examined for galactorrhea. • - Chest wall → burn, scar.
  • 29. 1- Prolactin level: • > 100 ng / ml → suggestive of adenoma. • > 300 ng/ ml → diagnostic of adenoma. • > 2000 ng/ ml→cavernous sinus invasion.
  • 30. 2- MRI brain: • - Detect all macroadenoma (> 1cm). • - Detect 70% of microadenoma(<1cm).
  • 31. • 3- Thyroid function tests. • 4- Others : - Liver function test. - Kidney function test.
  • 32. Treatment of the cause • - Treatment of hypothyroidism (thyroxine). • -stop drugs causing hyperprolactinemia. • -PCO,Liver,renal,.....
  • 33. 2- Dopamine agonists: • Acts on D2 receptors but also D1,Alpha adrenergic. • 1. Bromocreptine (parlodel): tablet = 2.5 mg oral or even vaginal.- start with ½ tablet → ↑ gradually ,better during meals. • - Side effects1- Nausea & vomiting. • 2- Postural hypotension.3- Headache. • 4- Abdominal cramps.
  • 34. . Lisuride (dopergine): • More potent. - Less side effects.
  • 35. 3. Cabergoline (dostinex): • Selective D2 Agonist tablet 0.5 mg • - Long acting. • - More potent. • - Less side effects
  • 36. . Quinagolid (norprolac): • non-ergot preparation (D2 receptors), • less side effects
  • 37. 3- Trans-sphenoid surgery: • For Pituitary adenoma only if : • - No response to medical ttt. • - Causing visual field defect. • - TTT is not tolerable.